CLEMENTI, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 688
NA - Nord America 572
AS - Asia 356
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 1.633
Nazione #
US - Stati Uniti d'America 570
SE - Svezia 346
CN - Cina 189
IT - Italia 166
SG - Singapore 145
RU - Federazione Russa 90
FI - Finlandia 35
DE - Germania 20
IE - Irlanda 16
SA - Arabia Saudita 6
IN - India 5
AU - Australia 4
RO - Romania 4
BR - Brasile 3
CM - Camerun 3
IR - Iran 3
A1 - Anonimo 2
CA - Canada 2
CH - Svizzera 2
EU - Europa 2
FR - Francia 2
GB - Regno Unito 2
HK - Hong Kong 2
PH - Filippine 2
PL - Polonia 2
TW - Taiwan 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
KR - Corea 1
MA - Marocco 1
NL - Olanda 1
PK - Pakistan 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.633
Città #
Ashburn 105
Milan 95
Singapore 93
Shanghai 88
Princeton 81
Lawrence 78
New York 64
Moscow 41
Helsinki 29
Boardman 18
Dublin 16
Guangzhou 14
Los Angeles 11
Shenzhen 10
Beijing 9
Dallas 9
Rome 9
Washington 9
Santa Clara 6
Seattle 6
Jeddah 5
Jiaxing 5
Lappeenranta 5
Pune 5
Xi'an 5
Ancona 4
Turin 4
Bologna 3
Busto Arsizio 3
Frankfurt Am Main 3
Hangzhou 3
Kassel 3
Lansing 3
Melbourne 3
Nanjing 3
Pisa 3
Riccione 3
São Paulo 3
Wuxi 3
Ascoli Piceno 2
Aversa 2
Cernusco sul Naviglio 2
Como 2
Gatchina 2
Kunming 2
Las Vegas 2
London 2
Newark 2
Padova 2
Portland 2
South San Francisco 2
Taipei 2
Tongling 2
Varese 2
Zurich 2
Andover 1
Bacoor 1
Bari 1
Bergamo 1
Bloemfontein 1
Borås 1
Buffalo 1
Central 1
Changzhi 1
Charlottesville 1
Dongyang 1
Dresano 1
Espoo 1
Foshan 1
Frankfurt am Main 1
Haining 1
Hamilton 1
Hefei 1
Houston 1
Jinhua 1
Karachi 1
Kwai Chung 1
La Paz 1
Laojunmiao 1
Lübeck 1
Manila 1
Miami 1
Naples 1
Napoli 1
Nuremberg 1
Omsk 1
Palaia 1
Prague 1
Rabat 1
Riverside 1
Riyadh 1
Rockville 1
San Diego 1
San Francisco 1
Segrate 1
Shijiazhuang 1
St Petersburg 1
Sydney 1
Tehran 1
Volgograd 1
Totale 937
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 38
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 35
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 33
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 32
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 31
A Biologically-validated HCV E1E2 Heterodimer Structural Model 30
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 29
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 28
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 27
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 27
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 27
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 26
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 26
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 25
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 25
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 24
Answer to Photo Quiz: Scolecobasidium sp 24
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 23
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 23
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 23
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 22
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 22
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 22
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 21
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 21
Viral Respiratory Pathogens and Lung Injury 21
The interferon landscape along the respiratory tract impacts the severity of COVID-19 21
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 21
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 20
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 20
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 20
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 20
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 20
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 20
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 20
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 20
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 19
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 19
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 19
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 19
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 19
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 19
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 19
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 18
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 18
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 18
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 18
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 18
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 18
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 17
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 17
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 17
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 16
HCV E2 core structures and mAbs: something is still missing 16
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 16
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 15
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 15
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 15
Role and potential therapeutic use of antibodies against herpetic infections 15
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 15
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 15
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 15
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 15
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 14
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 14
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 14
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 14
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 14
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 14
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 13
Beauveria bassiana Keratitis: A Case Series and Review of Literature 13
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 13
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 13
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 13
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 13
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 13
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 13
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 13
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 12
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 12
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 12
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 12
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 12
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 12
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 12
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 11
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 11
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 11
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic 11
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 11
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 10
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 10
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 10
Type III interferons disrupt the lung epithelial barrier upon viral recognition 10
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 9
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 9
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV) 9
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 8
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 8
Totale 1.793
Categoria #
all - tutte 25.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.897


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 9 0 0 0 0 3
2020/202128 5 1 0 3 6 0 3 4 0 6 0 0
2021/2022115 3 7 13 18 12 7 12 6 3 10 6 18
2022/2023643 191 151 74 8 7 82 43 45 24 2 11 5
2023/2024550 17 31 78 72 45 120 23 48 6 19 19 72
2024/2025413 178 42 48 77 68 0 0 0 0 0 0 0
Totale 1.851